Cite
HARVARD Citation
Oldenburg, J. et al. (2020). Assessing bleeding rates, related clinical impact and factor utilization in German hemophilia B patients treated with extended half-life rIX-FP compared to prior drug therapy. Current medical research and opinion. pp. 9-15. [Online].